(State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification Number) |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
(d) | Exhibits. |
Exhibit No. | Description | |||||||
99.1 | ||||||||
104 | Cover Page Interactive Data File (formatted as Inline XBRL) |
LUMENTUM HOLDINGS INC. | ||||||||||||||
By: | /s/ Wajid Ali | |||||||||||||
Name: | Wajid Ali | |||||||||||||
Title: | Chief Financial Officer | |||||||||||||
May 9, 2023 |
GAAP Results ($ in millions) | |||||||||||||||||||||||||||||
Q3 | Q2 | Q3 | Change | ||||||||||||||||||||||||||
FY 2023 | FY 2023 | FY 2022 | Q/Q | Y/Y | |||||||||||||||||||||||||
Net revenue | $383.4 | $506.0 | $395.4 | (24.2)% | (3.0)% | ||||||||||||||||||||||||
Gross margin | 29.2% | 32.8% | 42.3% | (360)bps | (1,310)bps | ||||||||||||||||||||||||
Operating margin (loss) | (13.4)% | (4.3)% | 11.8% | (910)bps | (2,520)bps | ||||||||||||||||||||||||
Non-GAAP Results ($ in millions) | |||||||||||||||||||||||||||||
Q3 | Q2 | Q3 | Change | ||||||||||||||||||||||||||
FY 2023 | FY 2023 | FY 2022 | Q/Q | Y/Y | |||||||||||||||||||||||||
Net revenue | $383.4 | $506.0 | $395.4 | (24.2)% | (3.0)% | ||||||||||||||||||||||||
Gross margin | 40.8% | 44.9% | 49.5% | (410)bps | (870)bps | ||||||||||||||||||||||||
Operating margin | 13.4% | 23.1% | 26.5% | (970)bps | (1,310)bps |
Net Revenue by Segment ($ in millions) | |||||||||||||||||||||||||||||||||||
Q3 | % of | Q2 | Q3 | Change | |||||||||||||||||||||||||||||||
FY 2023 | Net Revenue | FY 2023 | FY 2022 | Q/Q | Y/Y | ||||||||||||||||||||||||||||||
Optical Communications | $ | 335.1 | 87.4 | % | $ | 448.8 | $ | 344.2 | (25.3) | % | (2.6) | % | |||||||||||||||||||||||
Lasers | 48.3 | 12.6 | % | 57.2 | 51.2 | (15.6) | % | (5.7) | % | ||||||||||||||||||||||||||
Total | $ | 383.4 | 100.0 | % | $ | 506.0 | $ | 395.4 | (24.2) | % | (3.0) | % |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
April 1, 2023 | April 2, 2022 | April 1, 2023 | April 2, 2022 | ||||||||||||||||||||
Net revenue | $ | 383.4 | $ | 395.4 | $ | 1,396.2 | $ | 1,290.5 | |||||||||||||||
Cost of sales | 252.7 | 212.6 | 850.4 | 636.3 | |||||||||||||||||||
Amortization of acquired developed intangibles | 18.7 | 15.6 | 66.4 | 47.3 | |||||||||||||||||||
Gross profit | 112.0 | 167.2 | 479.4 | 606.9 | |||||||||||||||||||
Operating expenses: | |||||||||||||||||||||||
Research and development | 85.4 | 56.7 | 233.9 | 164.0 | |||||||||||||||||||
Selling, general and administrative | 76.4 | 63.8 | 280.5 | 196.1 | |||||||||||||||||||
Restructuring and related charges | 1.6 | (0.1) | 24.8 | (1.1) | |||||||||||||||||||
Total operating expenses | 163.4 | 120.4 | 539.2 | 359.0 | |||||||||||||||||||
Income (loss) from operations | (51.4) | 46.8 | (59.8) | 247.9 | |||||||||||||||||||
Interest expense | (8.7) | (19.7) | (26.1) | (53.7) | |||||||||||||||||||
Other income, net | 11.4 | 2.2 | 28.9 | 3.8 | |||||||||||||||||||
Income (loss) before income taxes | (48.7) | 29.3 | (57.0) | 198.0 | |||||||||||||||||||
Income tax provision (benefit) | (9.4) | 3.3 | 14.4 | 33.8 | |||||||||||||||||||
Net income (loss) | $ | (39.3) | $ | 26.0 | $ | (71.4) | $ | 164.2 | |||||||||||||||
Net income (loss) per share: | |||||||||||||||||||||||
Basic | $ | (0.57) | $ | 0.37 | $ | (1.05) | $ | 2.28 | |||||||||||||||
Diluted | $ | (0.57) | $ | 0.35 | $ | (1.05) | $ | 2.19 | |||||||||||||||
Shares used to compute net income (loss) per share: | |||||||||||||||||||||||
Basic | 68.6 | 71.0 | 68.3 | 72.0 | |||||||||||||||||||
Diluted | 68.6 | 74.5 | 68.3 | 75.1 |
April 1, 2023 | July 2, 2022 | ||||||||||
ASSETS | |||||||||||
Current assets: | |||||||||||
Cash and cash equivalents | $ | 549.2 | $ | 1,290.2 | |||||||
Short-term investments | 1,118.0 | 1,258.8 | |||||||||
Accounts receivable, net | 278.0 | 262.0 | |||||||||
Inventories | 410.2 | 250.1 | |||||||||
Prepayments and other current assets | 108.2 | 78.1 | |||||||||
Total current assets | 2,463.6 | 3,139.2 | |||||||||
Property, plant and equipment, net | 482.9 | 360.5 | |||||||||
Operating lease right-of-use assets, net | 81.5 | 73.6 | |||||||||
Goodwill | 696.2 | 368.9 | |||||||||
Other intangible assets, net | 498.4 | 155.7 | |||||||||
Deferred tax asset | 116.2 | 27.0 | |||||||||
Other non-current assets | 15.2 | 37.3 | |||||||||
Total assets | $ | 4,354.0 | $ | 4,162.2 | |||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||||
Current liabilities: | |||||||||||
Accounts payable | $ | 198.7 | $ | 156.7 | |||||||
Accrued payroll and related expenses | 41.1 | 54.6 | |||||||||
Accrued expenses | 59.5 | 44.7 | |||||||||
Short-term debt | 426.2 | 409.9 | |||||||||
Operating lease liabilities, current | 14.4 | 11.2 | |||||||||
Other current liabilities | 29.0 | 39.4 | |||||||||
Total current liabilities | 768.9 | 716.5 | |||||||||
Long-term debt | 1,900.8 | 1,466.1 | |||||||||
Operating lease liabilities, non-current | 53.1 | 48.8 | |||||||||
Deferred tax liability | 17.5 | 12.9 | |||||||||
Other non-current liabilities | 75.7 | 42.9 | |||||||||
Total liabilities | 2,816.0 | 2,287.2 | |||||||||
Stockholders’ equity: | |||||||||||
Common stock, $0.001 par value, 990 authorized shares, 68.7 and 68.0 shares issued and outstanding as of April 1, 2023 and July 2, 2022, respectively | 0.1 | 0.1 | |||||||||
Additional paid-in capital | 1,671.4 | 2,003.6 | |||||||||
Accumulated deficit | (140.6) | (129.1) | |||||||||
Accumulated other comprehensive income | 7.1 | 0.4 | |||||||||
Total stockholders’ equity | 1,538.0 | 1,875.0 | |||||||||
Total liabilities and stockholders’ equity | $ | 4,354.0 | $ | 4,162.2 |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||
April 1, 2023 | December 31, 2022 | April 2, 2022 | April 1, 2023 | April 2, 2022 | |||||||||||||||||||||||||
Gross profit on GAAP basis | $ | 112.0 | $ | 166.2 | $ | 167.2 | $ | 479.4 | $ | 606.9 | |||||||||||||||||||
Stock-based compensation | 6.9 | 6.7 | 5.4 | 19.1 | 15.2 | ||||||||||||||||||||||||
Amortization of acquired intangibles | 18.7 | 24.8 | 15.6 | 66.4 | 47.3 | ||||||||||||||||||||||||
Amortization of acquired inventory fair value adjustments | 3.6 | 9.6 | — | 17.8 | — | ||||||||||||||||||||||||
Integration related costs | 6.7 | 2.8 | — | 9.5 | — | ||||||||||||||||||||||||
Other (gains) charges, net (1) | 8.4 | 16.9 | 7.4 | 35.2 | 0.9 | ||||||||||||||||||||||||
Gross profit on non-GAAP basis | $ | 156.3 | $ | 227.0 | $ | 195.6 | $ | 627.4 | $ | 670.3 | |||||||||||||||||||
Gross margin on non-GAAP basis | 40.8 | % | 44.9 | % | 49.5 | % | 44.9 | % | 51.9 | % | |||||||||||||||||||
Research and development on GAAP basis | $ | 85.4 | $ | 75.8 | $ | 56.7 | $ | 233.9 | 164.0 | ||||||||||||||||||||
Stock-based compensation | (11.0) | (10.6) | (5.4) | (31.2) | (15.8) | ||||||||||||||||||||||||
Integration related costs | (0.5) | (0.8) | — | (1.3) | — | ||||||||||||||||||||||||
Write-off of in-process research and development intangible assets (2) | (11.5) | — | — | (11.5) | — | ||||||||||||||||||||||||
Other charges | (0.3) | — | (0.6) | (2.6) | (0.7) | ||||||||||||||||||||||||
Research and development on non-GAAP basis | $ | 62.1 | $ | 64.4 | $ | 50.7 | $ | 187.3 | $ | 147.5 | |||||||||||||||||||
Selling, general and administrative on GAAP basis | $ | 76.4 | $ | 98.4 | $ | 63.8 | $ | 280.5 | $ | 196.1 | |||||||||||||||||||
Stock-based compensation | (15.2) | (19.3) | (12.5) | (54.1) | (44.4) | ||||||||||||||||||||||||
Stock-based compensation - acquisition related (3) | — | — | — | (11.9) | — | ||||||||||||||||||||||||
Amortization of acquired intangibles | (11.3) | (11.3) | (5.8) | (31.9) | (17.0) | ||||||||||||||||||||||||
Acquisition related costs (4) | — | — | — | (16.2) | — | ||||||||||||||||||||||||
Integration related costs | (3.4) | (4.4) | — | (8.4) | — | ||||||||||||||||||||||||
Litigation matters (5) | — | (7.8) | — | (7.8) | — | ||||||||||||||||||||||||
Other charges, net | (3.7) | (9.7) | (5.5) | (15.6) | (17.3) | ||||||||||||||||||||||||
Selling, general and administrative on non-GAAP basis | $ | 42.8 | $ | 45.9 | $ | 40.0 | $ | 134.6 | $ | 117.4 | |||||||||||||||||||
Income (Loss) from operations on GAAP basis | $ | (51.4) | $ | (21.9) | $ | 46.8 | $ | (59.8) | $ | 247.9 | |||||||||||||||||||
Stock-based compensation | 33.1 | 36.6 | 23.3 | 104.4 | 75.4 | ||||||||||||||||||||||||
Stock-based compensation - acquisition related (3) | — | — | — | 11.9 | — | ||||||||||||||||||||||||
Amortization of acquired intangibles | 30.0 | 36.1 | 21.4 | 98.3 | 64.3 | ||||||||||||||||||||||||
Amortization of acquired inventory fair value adjustments | 3.6 | 9.6 | — | 17.8 | — | ||||||||||||||||||||||||
Acquisition related costs (4) | — | — | — | 16.2 | — | ||||||||||||||||||||||||
Integration related costs | 10.6 | 8.0 | — | 19.2 | — | ||||||||||||||||||||||||
Restructuring and related charges (6) | 1.6 | 13.9 | (0.1) | 24.8 | (1.1) | ||||||||||||||||||||||||
Write-off of in-process research and development intangible assets (2) | 11.5 | — | — | 11.5 | — | ||||||||||||||||||||||||
Litigation matters (5) | — | 7.8 | — | 7.8 | — | ||||||||||||||||||||||||
Other charges, net | 12.4 | 26.6 | 13.5 | 53.4 | 18.9 | ||||||||||||||||||||||||
Income from operations on non-GAAP basis | $ | 51.4 | $ | 116.7 | $ | 104.9 | $ | 305.5 | $ | 405.4 | |||||||||||||||||||
Operating margin on non-GAAP basis | 13.4 | % | 23.1 | % | 26.5 | % | 21.9 | % | 31.4 | % | |||||||||||||||||||
Interest and other income (expense), net on GAAP basis | $ | 2.7 | $ | (5.2) | $ | (17.5) | $ | 2.8 | $ | (49.9) | |||||||||||||||||||
Foreign exchange (gains) losses, net | 0.5 | 4.1 | (1.1) | (4.4) | (1.7) | ||||||||||||||||||||||||
Non-cash interest expense on convertible notes | 6.0 | 6.2 | 17.7 | 17.9 | 48.8 | ||||||||||||||||||||||||
Interest and other income (expense), net on non-GAAP basis | $ | 9.2 | $ | 5.1 | $ | (0.9) | $ | 16.3 | $ | (2.8) | |||||||||||||||||||
Income (Loss) before income taxes on GAAP basis | $ | (48.7) | $ | (27.1) | $ | 29.3 | $ | (57.0) | $ | 198.0 | |||||||||||||||||||
Stock-based compensation | 33.1 | 36.6 | 23.3 | 104.4 | 75.4 | ||||||||||||||||||||||||
Stock-based compensation - acquisition related (3) | — | — | — | 11.9 | — | ||||||||||||||||||||||||
Acquisition related costs (4) | — | — | — | 16.2 | — | ||||||||||||||||||||||||
Integration related costs | 10.6 | 8.0 | — | 19.2 | — | ||||||||||||||||||||||||
Amortization of acquired intangibles | 30.0 | 36.1 | 21.4 | 98.3 | 64.3 | ||||||||||||||||||||||||
Amortization of acquired inventory fair value adjustments | 3.6 | 9.6 | — | 17.8 | — | ||||||||||||||||||||||||
Restructuring and related charges (6) | 1.6 | 13.9 | (0.1) | 24.8 | (1.1) | ||||||||||||||||||||||||
Litigation matters (5) | — | 7.8 | — | 7.8 | — | ||||||||||||||||||||||||
Write-off of in-process research and development intangible assets (2) | 11.5 | — | — | 11.5 | — | ||||||||||||||||||||||||
Foreign exchange (gains) losses, net | 0.5 | 4.1 | (1.1) | (4.4) | (1.7) | ||||||||||||||||||||||||
Non-cash interest expense on convertible notes | 6.0 | 6.2 | 17.7 | 17.9 | 48.8 | ||||||||||||||||||||||||
Other charges, net | 12.4 | 26.6 | 13.5 | 53.4 | 18.9 | ||||||||||||||||||||||||
Income before income taxes on non-GAAP basis | $ | 60.6 | $ | 121.8 | $ | 104.0 | $ | 321.8 | $ | 402.6 | |||||||||||||||||||
Income tax provision (benefit) on GAAP basis | $ | (9.4) | $ | 4.6 | $ | 3.3 | $ | 14.4 | $ | 33.8 | |||||||||||||||||||
Non-GAAP income tax reconciling adjustments | 18.2 | 13.1 | 11.8 | 32.3 | 24.6 | ||||||||||||||||||||||||
Income tax provision on non-GAAP basis | $ | 8.8 | $ | 17.7 | $ | 15.1 | $ | 46.7 | $ | 58.4 | |||||||||||||||||||
Net income (loss) on GAAP basis | $ | (39.3) | $ | (31.7) | $ | 26.0 | $ | (71.4) | $ | 164.2 | |||||||||||||||||||
Stock-based compensation | 33.1 | 36.6 | 23.3 | 104.4 | 75.4 | ||||||||||||||||||||||||
Stock-based compensation - acquisition related (3) | — | — | — | 11.9 | — | ||||||||||||||||||||||||
Acquisition related costs (4) | — | — | — | 16.2 | — | ||||||||||||||||||||||||
Integration related costs | 10.6 | 8.0 | — | 19.2 | — | ||||||||||||||||||||||||
Amortization of acquired intangibles | 30.0 | 36.1 | 21.4 | 98.3 | 64.3 | ||||||||||||||||||||||||
Amortization of acquired inventory fair value adjustments | 3.6 | 9.6 | — | 17.8 | — | ||||||||||||||||||||||||
Restructuring and related charges (6) | 1.6 | 13.9 | (0.1) | 24.8 | (1.1) | ||||||||||||||||||||||||
Write-off of in-process research and development intangible assets (2) | 11.5 | — | — | 11.5 | — | ||||||||||||||||||||||||
Litigation matters (5) | — | 7.8 | — | 7.8 | — | ||||||||||||||||||||||||
Foreign exchange (gains) losses, net | 0.5 | 4.1 | (1.1) | (4.4) | (1.7) | ||||||||||||||||||||||||
Non-cash interest expense on convertible notes | 6.0 | 6.2 | 17.7 | 17.9 | 48.8 | ||||||||||||||||||||||||
Non-GAAP income tax reconciling adjustments | (18.2) | (13.1) | (11.8) | (32.3) | (24.6) | ||||||||||||||||||||||||
Other charges, net | 12.4 | 26.6 | 13.5 | 53.4 | 18.9 |
Net income on non-GAAP basis | $ | 51.8 | $ | 104.1 | $ | 88.9 | $ | 275.1 | $ | 344.2 | |||||||||||||||||||
Net income per share on non-GAAP basis | $ | 0.75 | $ | 1.52 | $ | 1.19 | $ | 3.97 | $ | 4.58 | |||||||||||||||||||
Shares used in per share calculation - diluted on GAAP basis | 68.6 | 68.3 | 74.5 | 68.3 | 75.1 | ||||||||||||||||||||||||
Non-GAAP adjustment (7) | 0.1 | 0.3 | — | 1.0 | — | ||||||||||||||||||||||||
Shares used in per share calculation - diluted on non-GAAP basis | 68.7 | 68.6 | 74.5 | 69.3 | 75.1 | ||||||||||||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||
April 1, 2023 | December 31, 2022 | April 2, 2022 | April 1, 2023 | April 2, 2022 | |||||||||||||||||||||||||
GAAP net income (loss) | $ | (39.3) | $ | (31.7) | $ | 26.0 | $ | (71.4) | $ | 164.2 | |||||||||||||||||||
Interest and other expense, net | (2.7) | 5.2 | 17.5 | (2.8) | 49.9 | ||||||||||||||||||||||||
Income tax provision (benefit) | (9.4) | 4.6 | 3.3 | 14.4 | 33.8 | ||||||||||||||||||||||||
Depreciation | 27.7 | 26.4 | 20.2 | 78.6 | 61.2 | ||||||||||||||||||||||||
Amortization of acquired intangibles | 30.0 | 36.1 | 21.4 | 98.3 | 64.3 | ||||||||||||||||||||||||
EBITDA | 6.3 | 40.6 | 88.4 | 117.1 | 373.4 | ||||||||||||||||||||||||
Amortization of inventory fair value adjustments | 3.6 | 9.6 | — | 17.8 | — | ||||||||||||||||||||||||
Restructuring and related charges | 1.6 | 13.9 | (0.1) | 24.8 | (1.1) | ||||||||||||||||||||||||
Stock-based compensation | 33.1 | 36.6 | 23.3 | 116.3 | 75.4 | ||||||||||||||||||||||||
Acquisition related costs | — | — | — | 16.2 | — | ||||||||||||||||||||||||
Integration related costs | 10.6 | 8.0 | — | 19.2 | — | ||||||||||||||||||||||||
Write-off of in-process research and development intangible assets | 11.5 | — | — | 11.5 | — | ||||||||||||||||||||||||
Other charges, net | 10.3 | 24.7 | 13.5 | 49.4 | 18.9 | ||||||||||||||||||||||||
Adjusted EBITDA | $ | 77.0 | $ | 133.4 | $ | 125.1 | $ | 372.3 | $ | 466.6 | |||||||||||||||||||
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end
COVER PAGE |
May 09, 2023 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Document Period End Date | May 09, 2023 |
Entity Registrant Name | Lumentum Holdings Inc. |
Entity Incorporation, State or Country Code | DE |
Entity File Number | 001-36861 |
Entity Tax Identification Number | 47-3108385 |
Entity Address, Address Line One | 1001 Ridder Park Drive |
Entity Address, City or Town | San Jose |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 95131 |
City Area Code | 408 |
Local Phone Number | 546-5483 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | false |
Title of each class | Common Stock, par value of $0.001 per share |
Trading Symbol(s) | LITE |
Name of each exchange on which registered | NASDAQ |
Entity Central Index Key | 0001633978 |
Amendment Flag | false |
U/+C R>7@OCMIVE/[ [4+4).$;4#(N^R#F:O#
M0?C0,#(K#I]K:> H6]S&C(*+V!?@^49*\]:PY]GRWQ'C_P!02P,$% @
MDSZI5I^@&_"Q @ X@P T !X;"]S='EL97,N>&ULW5=M:]LP$/XK0C]@
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MS8).IF(M>05TK*B/\.M,DP#HG%%>* 6KC68#A\EC%'S8 Y?R 5KXK;J*W5RHY_U=3
M_ 102P,$% @ DSZI5I>*NQS $P( L !?
M!<+;3 _@)1L+>^:7]-M&8B&ML!,,SQ0,
MU2@:T7 G'EY./,S6.> ]@8D #:/(^<"/8$
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MC0J@986]05S7>=2.CG&FSRY,6$R8VR$/F" Q^">],%=Y$/$1V9\M%Z>/0S$Y^ VE%Z2_.QH
M"5Z9>?1&E.%TQ**\S8LM-RUD0\5#"K)CI!4]^XL0'0RB 1Y1D!VC_ ''AXO=
MJ,5.^'/7]HB-DWK#XL>(_MC3EGA%G2DMH\@25AHW&>ZP;9X+AD6S "&Z\J/;
M,OM*%^6VALBJPP'NC)=O/H"EP!-\W3LASZ?9&C&/C9WHA<35W%AM#0ML?N-:
MXG!KB1*3ZB)$6ZES SU;LF.DXYI\SQ3F)=V